Studies related to Insulin and Fish Oil

Effects Of Purified Eicosapentaenoic And Docosahexaenoic Acids On Glycemic Control, Blood Pressure, And Serum Lipids In Type 2 Diabetic Patients With Treated Hypertension

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 59
Sex Both Genders
Age Range 45-64, 65+
Body Types Obese, Overweight
Notes for this study:
4g of either EPA or DHA (or placebo) in type II diabetics for 6 weeks noted increases in fasting glucose following EPA (1.40 +/- 0.29 mmol/L) and DHA (0.98 +/- 0.29 mmol/L) without affecting any other measured diabetic or cardiometabolic parameter.

Full details on all 10 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.